Torrent Pharmaceuticals Ltd Quarterly Result

Torrent Pharmaceuticals Ltd Quarterly Result

Image

Torrent Pharmaceuticals Ltd

NSE: TORNTPHARM

Net Profit - Last Quarter

₹ 364 Cr.

Last updated on: Jun 06, 2026

Torrent Pharmaceuticals Ltd Quarterly Results Key Highlights

  • The revenue of Torrent Pharmaceuticals Ltd for the Mar '26 is ₹ 4180 crore as compare to the Dec '25 revenue of ₹ 3290 crore.
  • This represent the growth of 27.05% The ebitda of Torrent Pharmaceuticals Ltd for the Mar '26 is ₹ 1273 crore as compare to the Dec '25 ebitda of ₹ 1065 crore.
  • This represent the growth of 19.53% The net profit of Torrent Pharmaceuticals Ltd for the Mar '26 is ₹ 364 crore as compare to the Dec '25 net profit of ₹ 635 crore.
  • This represent the decline of -42.68%.

Torrent Pharmaceuticals Ltd Quarterly Results Analysis

Market Price of Torrent Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Torrent Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
05 Jun 20264418.7
04 Jun 20264337.65
03 Jun 20264369.5
02 Jun 20264314.25
01 Jun 20264348.75
29 May 20264394.15
27 May 20264540.9
26 May 20264451.2
25 May 20264571.9
22 May 20264484.15

Historical Revenue of Torrent Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Torrent Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Torrent Pharmaceuticals Ltd

No data available

* All values are in crore

Torrent Pharmaceuticals Ltd News Hub

Torrent Pharmaceuticals announces change in senior management

Torrent Pharmaceuticals announced that Pranav Mehta has been elevated as Executive Director from Vic

Read more

13 Aug 24

Torrent Pharma hits life as Gujarat unit gets EIR from USFDA

Earlier on 12 June 2024, the pharmaceutical company informed that the US FDA had conducted a pre-app

Read more

30 Aug 24

Torrent Pharma's Madhya Pradesh facility concludes GMP inspection with 1 observation

The GMP inspection was conducted from 16 September to 20 September 2024. At the conclusion of the in

Read more

20 Sept 24

Torrent Pharmaceuticals announces board meeting date

Torrent Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 25 October 2

Read more

10 Oct 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

July 2024

Transcript

May 2024

Transcript

Feb 2024

Transcript

Aug 2023

Transcript

May 2023

Transcript

Sep 2022

PPT

About Torrent Pharmaceuticals Ltd

  • Torrent Pharmaceuticals Limited is a leading player in the Indian pharmaceutical sector, concentrating on the chronic and sub-chronic therapeutic segments.
  • The Company has established itself as a leader in developing niche pharmaceutical solutions through its patient-centric innovation.
  • The Company is a dominant player in the therapeutic areas of Cardiovascular (CV), Central Nervous System (CNS), Vitamins and Nutrients (VMN), Gastro-Intestinal (GI) and Anti-Diabetes (AD) therapies in India.
  • It has a strong international presence across more than 40 countries with operations in regulated and emerging markets, such as the US, Europe, Germany, Brazil and Rest of the World. The Company operates through its wholly-owned subsidiaries spread across 15 countries with major setups in the US, Germany and Brazil.

FAQs for Quarterly Results of Torrent Pharmaceuticals Ltd

What key financial metrics are included in Torrent Pharmaceuticals Ltd's quarterly results?

Key financial metrics in Torrent Pharmaceuticals Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Torrent Pharmaceuticals Ltd announce its quarterly results?

Torrent Pharmaceuticals Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Torrent Pharmaceuticals Ltd's quarterly performance impact its stock price?

Torrent Pharmaceuticals Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Torrent Pharmaceuticals Ltd's quarterly results on dividends?

The impact of Torrent Pharmaceuticals Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Torrent Pharmaceuticals Ltd's quarterly results?

Yes, Torrent Pharmaceuticals Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions